Status:
UNKNOWN
Prevalance of non_ Alcoholic Fatty Liver Diseases in Patient With Inflammatory Bowel Diseases Attending Assiut University Hospitals
Lead Sponsor:
Assiut University
Conditions:
Inflammatory Bowel Disease Patients
Eligibility:
All Genders
Brief Summary
To assess the prevalance of non\_alcoholic fatty liver diseases in inflammatory bowel disease patients and its relation to type of treatment given and disease severity
Detailed Description
Inflammatory bowel diseases (IBD) including Crohns disease (CD) and ulcerative colitis (UC) are chronic relapsing disorders that often require long-term therapy and follow up . They are recognized fo...
Eligibility Criteria
Inclusion
- Crohn's disease (CD) patients
- ulcerative colitis (UC) patients
Exclusion
- diabetic patients
- BMI equal and more than 30.0-34.9(class I obesity)
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04328259
Start Date
October 1 2020
End Date
April 1 2022
Last Update
May 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.